Stay updated on Lintuzumab in CLAG-M for AML Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.

Latest updates to the Lintuzumab in CLAG-M for AML Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.6.2) has been added to the study record history, and the previous revision (v3.6.0) has been removed. This update updates the historical log for the ClinicalTrials.gov record rather than changes to the study data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record now shows that recruitment is not currently accepting participants, indicating the trial is not seeking new subjects. A new revision (v3.6.0) was added and the previous revision (v3.5.5) was removed.SummaryDifference0.4%

- Check25 days agoChange DetectedA new Revision: v3.5.5 appears in the record history, signaling a recent update to the study record; the previous Revision: v3.5.4 entry seems to be removed from the visible history.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 in the page history, indicating a new version of the study record history. This update changes only the metadata shown on the page and does not modify the underlying data or user-facing content.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page history, indicating a new maintenance release. This change does not modify study details or results presented on the page.SummaryDifference0.2%

- Check68 days agoChange DetectedNo changes were detected in the provided additions/deletions for this page.SummaryDifference0.1%

Stay in the know with updates to Lintuzumab in CLAG-M for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.